Xilio Therapeutics, Inc. ( XLO) - Key Metrics
XLO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.16 | $0.54 | -$0.02 | -$0.03 |
| 2025Q3 | $1.85 | -$1.58 | -$1.70 | -$1.70 |
| 2025Q2 | $2.18 | -$4.28 | -$3.91 | -$4.02 |
| 2025Q1 | $0.55 | -$2.49 | $5.43 | $5.43 |
XLO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 4.12 |
| 2025Q3 | ? | -1.86 |
| 2025Q2 | ? | -0.56 |
| 2025Q1 | ? | -1.02 |
XLO
Price: $8.79
52 week price:
Earnings Per Share: -2.28 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 18100
Market Capitalization: 46.1 million